Literature DB >> 21908682

Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease.

Hong H Keo1, Iris Baumgartner, Alan T Hirsch, Sue Duval, Ph Gabriel Steg, Blandine Pasquet, Deepak L Bhatt, Joachim Roether.   

Abstract

We aimed to evaluate whether carotid intima-media thickness (CIMT) or the presence of plaque can confer additional predictive value of future cardiovascular (CV) ischemic events in patients with pre-existing atherosclerotic vascular disease. We identified 2317 patients enrolled in the REduction of Atherothrombosis for Continued Health (REACH) registry who had atherosclerotic vascular disease and baseline CIMT measurements. The entire range of CIMT was divided into quartiles and the fourth quartile (≥ 1.5 mm) was defined as carotid plaque. Mean ± standard deviation baseline CIMT was 1.31 ± 0.65 mm. Associated CV ischemic events and vascular-related hospitalizations were evaluated over a 2-year follow-up. There was a positive increase in adjusted hazard ratios (HRs) for all-cause mortality (p = 0.04 for trend) and the quadruple endpoint (CV death, myocardial infarction (MI), stroke, hospitalization for CV events) with increasing quartiles of CIMT (p = 0.0008 for trend), which was mainly driven by the fourth quartile (carotid plaque). HRs for all-cause mortality, CV death, CV death/MI/stroke and the quadruple endpoint comparing the highest (carotid plaque) with the lowest CIMT quartile were 2.09 (95% CI, 1.07-4.10; p = 0.03); 2.49 (1.10-5.67; p = 0.03); 1.71 (1.10-2.67; p = 0.02); and 1.73 (1.31-2.27; p = 0.0001). In conclusion, our analyses suggest that the presence of carotid plaque, rather than the thickness of intima-media, appears to be associated with increased risk of CV morbidity and mortality, but confirmation of these findings in other population and prospective studies is required.

Entities:  

Mesh:

Year:  2011        PMID: 21908682     DOI: 10.1177/1358863X11419997

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  3 in total

1.  Impact of Atorvastatin Combined with Ezetimibe for the Treatment of Carotid Atherosclerosis in Patients with Coronary Heart Disease.

Authors:  Ping Luo; Lixia Wang; Haohui Zhu; Song Du; Guanggong Wang; Shoukun Ding
Journal:  Acta Cardiol Sin       Date:  2016-09       Impact factor: 2.672

2.  Associations among different functional and structural arterial wall properties and their relations to traditional cardiovascular risk factors in healthy subjects: a cross-sectional study.

Authors:  Mojca Lunder; Miodrag Janic; Natasa Kejzar; Miso Sabovic
Journal:  BMC Cardiovasc Disord       Date:  2012-04-25       Impact factor: 2.298

3.  Additive Prognostic Value of Carotid Plaque Score to Enhance the Age, Creatinine, and Ejection Fraction Score in Patients with Acute Coronary Syndrome.

Authors:  Takuya Nakahashi; Hayato Tada; Kenji Sakata; Akihiro Nomura; Miho Ohira; Mika Mori; Masayuki Takamura; Kenshi Hayashi; Masakazu Yamagishi; Masa-Aki Kawashiri
Journal:  J Atheroscler Thromb       Date:  2018-01-26       Impact factor: 4.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.